Table 3. Odds ratios for mood disorder at 7 years follow-up for erythrocyte membrane phosphatidylethanolamine lipid levels at baseline in patients with mood disorders.
Unadjusted |
Model 1a |
Model 2b |
||||
---|---|---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | |
ω -6 Fatty Acids | ||||||
Linolenic acid (18:2n-6) | 0.324 (0.111–0.942) | 0.038 | 0.254 (0.078–0.827) | 0.023 | 0.287 (0.086–0.950) | 0.041 |
r-Linolenic acid (18:3n-6) | 1.835 (1.069–3.150) | 0.028 | 1.881 (1.083–3.268) | 0.025 | 1.800 (1.028–3.150) | 0.040 |
Docosadienoic acid (22:2n-6) | 1.856 (1.095–3.145) | 0.022 | 1.810 (1.051–3.117) | 0.033 | 1.776 (1.029–3.065) | 0.039 |
ω-3 Fatty Acids | ||||||
Eicosapentaenoic acid (20:5n-3) | 0.383 (0.185–0.793) | 0.010 | 0.372 (0.178–0.781) | 0.009 | 0.390 (0.172–0.883) | 0.024 |
Docosahexaenoic acid (22:6n-3) | 0.506 (0.276–0.928) | 0.028 | 0.517 (0.279–0.960) | 0.037 | 0.488 (0.261–0.913) | 0.025 |
Sums and ratios | ||||||
Sum of ω-3 fatty acids | 0.453 (0.236–0.869) | 0.017 | 0.446 (0.228–0.874) | 0.019 | 0.436 (0.200–0.950) | 0.037 |
ω -6 to ω-3 fatty acids ratio | 1.894 (1.075–3.338) | 0.027 | 1.843 (1.035–3.284) | 0.038 | 1.815 (1.024–3.289) | 0.041 |
Abbreviations: PUFAs, polyunsaturated fatty acids.
Adjusted for age, sex and smoking at baseline.
Adjusted for age, sex, smoking, MADRS score and ω -3 PUFA/placebo group status at baseline.